Lu-177-labeled peptide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lu-177-labeled peptide, covering 2012-03-19 to 2012-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer [Phase 1]